Ongoing Technology Transfer Negotiation after Business Meetings

CDA, Due Diligence, Data Room, FTO, MTA, CMC, IND
We provide continued support to
help buyer companies maintain interest
and proceed to the next stages following initial meetings

After meeting with potential buyers,
we support them in sustaining interest in the technologies we introduce and help guide them through the next steps.
Once a CDA (Confidential Disclosure Agreement) is signed, technical and research teams from both parties hold online group meetings to discuss the technology in depth and engage in detailed Q&A.
A data room is then opened to review the credibility of supporting data, including results from in-vitro and in-vivo animal studies.
Due diligence is conducted, covering IP-related Freedom to Operate (FTO) analysis, CMC (Chemistry, Manufacturing, and Controls), and review of documents related to FDA IND (Investigational New Drug) submissions.
We provide comprehensive consulting support throughout the entire process to ensure smooth and effective progress.

Main Services

Post-Meeting Activities

Summarize results of meetings with buyer companies
Provide feedback to inventors regarding meeting outcomes
Outline any additional materials inventors need to prepare
Deliver supplemental materials to buyers and follow up on Q&A
Conduct technology transfer-related activities

Contract Process and Completion of Technology Transfer Agreement

CDA(Confidential Disclosure Agreement)
LOI(Letter of Intention)
MOU(Memorandum of Understanding)
Target Engagement and Biomarker
Genetic Mutation and animal model
CMC Due Diligence questionnaire
Competitive landscape and market analysis
IP Due Diligence
MTA(Material Transfer Agreement)
Data room due deligence
Agreement for the payment of the signing fee
Term sheet
Option agreement
Contract